Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: A common defective stem cell?

Leukemia Research

Volumn 33, Issue 6, 2009, Pages 854-855

  Tabaczewski, Piotr ^a   Nadesan, Sushani ^b   Lim, Seah H ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TEXAS ONCOLOGY   (United States)

Author keywords

CLL; ET; Jak 2 mutation; Zap 70

Indexed keywords

HYDROXYUREA; PROTEIN KINASE ZAP 70;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; GENE MUTATION; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTHEMIA; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; HUMANS; JANUS KINASE 2; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; NEOPLASTIC STEM CELLS; THROMBOCYTHEMIA, ESSENTIAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 63349083545     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.09.002     Document Type: Article

References (10)

1. Gabrail N.Y., and Martin T.W. Coexistence of essential thrombocythemia and chronic lymphocytic leukemia. Acta Haematol 85 (1991) 31-33
2. Marcos Sanchez F., Juarez Ucerlay F., Lobato de Blas C., Llanos del Ama M.L., and Duran Perez-Navarro A. Simultaneous presentation of chronic lymphocytic leukosis and essential thrombocythemia. Ann Med Interne 12 (1995) 566
3. Bizzaro N. Chronic lymphocytic leukaemia in a patient with essential thrombocythemia. Clin Lab Haematol 20 (1998) 377-379
4. Robak T., Urbanska-Rys H., Gora-Tybor J., Wawrzyniak E., Korycka A., Bartkowiak J., et al. Coexistence of chronic lymphocytie leukemia and essential thrombocythemia. Leuk Lymphoma 44 (2003) 1425-1431
5. Henry L., Carillo S., Jourdan E., Arnaud A., Brun S., and Lavabre-Bertrand T. Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F Jak2 mutation in the lymphoid compartment. Am J Hematol 82 (2007) 500-501
6. Wiestner A., Rosenwld A., Barry T.S., Wright G., Davis R.E., Henrickson S.E., et al. Zap-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin gene. Inferior clinical outcome and distinct gene expression profile. Blood 101 (2003) 4944-4951
7. Levine R.L., Pardanani A., Tefferi A., and Gilliland G.D. Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders. Nat Rev Cancer 7 (2007) 673-683
8. James C., Ugo V., Le Couedic J.P., Staerk J., Delhommeau F., Lacout C., et al. A unique clonal JAK2 mutation leading to constitutive signaling causes polycythemia vera. Nature 434 (2005) 1144-1148
9. Raskind W.H., Jacobson R., Murphy S., Adamson J.W., and Fialkow P.J. Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia. J Clin Invest 75 (1985) 1388-1390
10. Campbell P.J., Baxton E.J., Beer P.A., Scott L.M., Bench A.J., Huntly B.J.P., et al. Mutation of Jak 2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation. Blood 108 (2006) 3548-3555